Our study supports that in vivo markers of neuronal density/function decrease and gliosis, which are histopathological features of AD, correlate with cognitive impairment, following spatial patterns seen in tau distribution and hypometabolism. This evidence concerns the gene MAPT and Cognitive impairment.